News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
The global life sciences technology company has named Dana Poff as chief operating officer, who joins the company from Icon.
“Clinical trials have significantly increased in complexity over the past 20 years, which has further solidified the continued need for technology advancements. While the industry uses technology to reduce some of the burden, it hasn’t yet fully adopted the technology to help reduce the burden for study sites who are the gateway to patients,” Poff told us.
In her new role at Teckro, she told us she wants to make this a reality for more sites globally.
“Having worked in health care and clinical trials for 28 years, I am looking to help empower sites in clinical research,” she added. “My role is to help Teckro continually improve our offerings while helping more study sites lessen their burdens so that our industry can move faster toward our shared goal: improving the health and well-being of people around the world.”